vimarsana.com

Page 18 - நினைவகம் ஹெர்மன் டெக்சாஸ் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Houston Chronicle: Build bridges so minorities can trust vaccine

Houston Chronicle: Build bridges so minorities can trust vaccine Houston Chronicle Robert Luckey, the first person in the Houston region to get the coronavirus vaccine, is a registered nurse at Memorial Hermann-Texas Medical Center, a U.S. Marine Corps veteran, and is assigned to the hospital’s COVID-19 unit. He is also Black. Why does that matter? Because the image of Luckey rolling up the sleeve of his blue scrubs to get the shot may help convince folks in Black and Latino communities that the much-anticipated vaccines are safe. Experience with a public health system that has often failed and abused people of color has sown a deep mistrust in those communities, even as COVID-19 ravages entire Black and Latino families and leaves others grappling with the economic fallout.

UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma

News Category Global Banking & Finance Reviews UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma The University of Texas Health Science Center at Houston (UTHealth) and Athersys, Inc. (NASDAQ: ATHX) announced today that the first patient has been enrolled in a clinical study evaluating MultiStem cell therapy for the potential early treatment of traumatic injuries and the subsequent complications that result. The MATRICS-1 (MultiStem Administration for Trauma Related Inflammation and Complications) study is being conducted at Memorial Hermann-Texas Medical Center, one of the busiest Level 1 trauma centers in the United States.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.